These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 14835492)

  • 1. [Comparative clinical examination of the therapeutic effect of some new tetraalkylpyprophosphates in myasthenia gravis pseudoparalytical].
    KOELZER PP; GIESEN J
    Ther Umsch Med Bibliogr; 1951 Feb; 7(11):172-82. PubMed ID: 14835492
    [No Abstract]   [Full Text] [Related]  

  • 2. [Myasthenia gravis therapy with SK 52].
    GIESEN J; KOELZER PP
    Med Klin; 1950 Dec; 45(48):1530-1. PubMed ID: 14805958
    [No Abstract]   [Full Text] [Related]  

  • 3. Octamethyl pyrophosphoramide in treatment of myasthenia gravis: further observations.
    SCHULMAN S; RIDER JA; RICHTER RB
    AMA Arch Neurol Psychiatry; 1953 May; 69(5):643-6. PubMed ID: 13039628
    [No Abstract]   [Full Text] [Related]  

  • 4. The hazard of cholinergic crisis during treatment of myasthenia gravis with octamethyl pyrophosphoramide.
    WILSON CW; WILLIAMS JP; MILLER DH
    Ann Intern Med; 1952 Sep; 37(3):574-9. PubMed ID: 12976955
    [No Abstract]   [Full Text] [Related]  

  • 5. Octamethyl pyrophosphoramide in the therapy of myasthenia gravis.
    GREGORY L; FUTCH ED; STONE CT
    Am J Med; 1952 Oct; 13(4):423-7. PubMed ID: 12985599
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of myasthenia gravis with octamethyl pyrophosphoramide; preliminary report.
    RIDER JA; SCHULMAN S; RICHTER RB; MOELLER HC; DUBOIS KP
    J Am Med Assoc; 1951 Mar; 145(13):967-72. PubMed ID: 14803293
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of octamethyl pyrophosphoramide in the treatment of myasthenia gravis; further observations.
    SCHULMAN S; RIDER A; RICHTER RB
    J Am Med Assoc; 1953 Aug; 152(18):1707-11. PubMed ID: 13069246
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experience in therapy of myasthenia with tetraisopropyl pyrophosphate (myastenol)].
    MOLINA ; GOTZE W
    Arztl Wochensch; 1952 Dec; 7(50):1186-7. PubMed ID: 13016389
    [No Abstract]   [Full Text] [Related]  

  • 9. [Tetra-ethyl-pyrophosphate in the treatment of myasthenia; study of blood cholinesterase].
    PASSOUANT P; LEVY A
    Rev Neurol (Paris); 1951 Jan; 84(1):88-91. PubMed ID: 14845372
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic strategy in myasthenia gravis].
    Tranchant C
    Rev Neurol (Paris); 2009 Feb; 165(2):149-54. PubMed ID: 19233080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies in myasthenia gravis: present status of therapy with octamethyl pyrophosphoramide (OMPA).
    OSSERMAN KE; KAPLAN LI
    Ann Intern Med; 1954 Jul; 41(1):108-11. PubMed ID: 13171793
    [No Abstract]   [Full Text] [Related]  

  • 12. Does this patient have myasthenia gravis?
    Scherer K; Bedlack RS; Simel DL
    JAMA; 2005 Apr; 293(15):1906-14. PubMed ID: 15840866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Radiological signs of myasthenia gravis].
    GIMES B
    Fortschr Geb Rontgenstr Nuklearmed; 1961 May; 94():643-50. PubMed ID: 13705463
    [No Abstract]   [Full Text] [Related]  

  • 14. [Rarely observed signs of fatigue in myasthenia gravis pseudoparalytica; origin of curare like substances in myasthenia].
    GROSSE-BROCKHOFF F; WELTE E
    Dtsch Med Wochenschr; 1950 May; 75(21):698-700. PubMed ID: 15427509
    [No Abstract]   [Full Text] [Related]  

  • 15. Some physiological experiments of nature in the field of neuromuscular function; tetra-ethyl pyrophosphate in the treatment of myasthenia gravis, potassium deficiency, potassium intoxication.
    HARVEY AM
    Proc Inst Med Chic; 1948 Nov; 17(8):182-8. PubMed ID: 18892688
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pseudoparalytical myasthenia gravis. Current position].
    Yáñez Polo MA
    Rev Clin Esp; 1969 Nov; 115(4):261-70. PubMed ID: 5379539
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cholinergic crisis in the treatment of myasthenia gravis].
    KUNTZ E; KAUFMANN L
    Nervenarzt; 1954 May; 25(5):209-11. PubMed ID: 13194075
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful use of sugammadex for caesarean section in a patient with myasthenia gravis.
    Soyoral L; Goktas U; Cegin MB; Baydi V
    Braz J Anesthesiol; 2017; 67(2):221-222. PubMed ID: 28236874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Misdiagnosis of myasthenia gravis.
    Wheeler SD
    J Natl Med Assoc; 1987 Apr; 79(4):425-9. PubMed ID: 3586040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Exacerbation of myasthenia gravis by pefloxacin].
    Vial T; Chauplannaz G; Brunel P; Leriche B; Evreux JC
    Rev Neurol (Paris); 1995 Apr; 151(4):286-7. PubMed ID: 7481384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.